Calcium N5-methyltetrahydrofolate

CAS No. 26560-38-3

Calcium N5-methyltetrahydrofolate( NSC-173328 )

Catalog No. M13814 CAS No. 26560-38-3

The calcium salt of levomefolic acid that has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 87 Get Quote
5MG 161 Get Quote
10MG 260 Get Quote
25MG 494 Get Quote
50MG 716 Get Quote
100MG 981 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Calcium N5-methyltetrahydrofolate
  • Note
    Research use only, not for human use.
  • Brief Description
    The calcium salt of levomefolic acid that has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers.
  • Description
    The calcium salt of levomefolic acid that has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC-173328
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Antifolate
  • Recptor
    Antifolate
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    26560-38-3
  • Formula Weight
    497.5179
  • Molecular Formula
    C20H23CaN7O6
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(O)CC[C@@H](C([O-])=O)NC(C1=CC=C(NCC2N(C)C3=C(NC(N)=NC3=O)NC2)C=C1)=O.[Ca+2]
  • Chemical Name
    L-Glutamic acid, N-[4-[[(2-amino-3,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-, calcium salt (1:1)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Levomefolate calcium

    A calcium salt of levomefolic acid.

  • Farletuzumab

    Farletuzumab (MORAb-003) is a humanized monoclonal antibody with a high affinity for folate receptor-α (FRα), acting as a potent inhibitor of FRα and impeding the growth of cells that overexpress this receptor, making it useful for cancer research.

  • Mirvetuximab

    Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1).